| Log in

Times Private Treaties Inks Pact With Novartis India

30 June, 2010

Times Private Treaties, the ad-for-equity investment arm of media house Bennett, Coleman & Company Ltd, has entered into a ‘strategic alliance’ with Novartis India Limited, a subsidiary of Swiss firm Novartis, the world’s second largest pharmaceutical company.

Novartis India Limited is the Indian listed arm of the Swiss major Novartis AG that makes brands such as Calcium Sandoz. It is not yet clear in what form BCCL has invested in Novartis India, as the listed company is yet to disclose any share issue.

The Swiss parent held 76.42% in the Indian arm after an open offer last year. Novartis scrip fell 2.63% in early morning trade on Wednesday which could be due to the fact that punters are booking profits in the stock. The scrip had hit a 52-week-high early this month as punters anticipated the parent to come up with an attractive offer to delist the firm as a follow-up to the new public listing norms.

Novartis is currently focusing on its brand “Calcium Sandoz Woman”, an over-the-counter calcium supplement that helps prevent osteoporosis.

The deal is part of Times Private Treaties’ investment portfolio in healthcare, pharma and wellness segment. It already has a client portfolio including HCG Oncology, Thyrocare, Apollo Clinic, Richfeel, Asia Cryocell (LifeCell), Avestha Gengraine, Holistic Healthcare (Ayurcare) and Lotus Eye Care Hospital Ltd.


Leave Your Comment
Exclusive: Samara Capital acquires several brands from Novartis

Exclusive: Samara Capital acquires several brands from Novartis

Bruhadeeswaran R 10 months ago
Private equity firm Samara Capital Partners Pvt. Ltd has acquired several brands...
Exclusive: Torrent Pharma buying select products of Novartis in India

Exclusive: Torrent Pharma buying select products of Novartis in India

Joseph Rai 1 year ago
Ahmedabad-based drugmaker Torrent Pharmaceuticals Ltd has agreed to acquire some...
News Roundup: Tata Sons Raises Rs 633 Crore by Selling TCS Shares

News Roundup: Tata Sons Raises Rs 633 Crore by Selling TCS Shares

TEAM VCC 9 years ago
 Novartis’ Open Offer Uncertain – The fate of the open...
No Comments

Times Private Treaties Inks Pact With Novartis India

Powered by WordPress.com VIP